Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST):an open-label, multicentre, randomised phase 3b trial

Autor: Silvio Danese, Severine Vermeire, Geert D'Haens, Julian Panés, Axel Dignass, Fernando Magro, Maciej Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Ivana Bravata, Frederic Lavie, Marco Daperno, Milan Lukáš, Alessandro Armuzzi, Mark Löwenberg, Daniel R Gaya, Laurent Peyrin-Biroulet, Rodolfo Rocca, Susana Lopes, Flavio Caprioli, Sandro Ardizzone, Ana Echarri Piudo, Paolo Gionchetti, Xavier Roblin, Ursula Seidler, David Andersson, Kamal Patel, Pierre Desreumaux, Simone Saibeni, Gustav From, Miroslav Fedurco, Milos Gregus, Yoram Bouhnik, Andreas Luegering, Rocco Cosintino, Ivan Bunganic, Jaime Ramos, Mariam Aguas Peris, Olivier Dewit, Mariabeatrice Principi, Emma Wesley, Paula Lago, Stephane Nancey, María Dolores Martín Arranz, Pieter Hindryckx, Ambrogio Orlando, Andrea Geccherle, Maria Laura Annunziata, Bu'hussain Hayee, Jozef Balaz, Francisco Portela, Cyrielle Gilletta, Torsten Kucharzik, Miguel Mínguez, Javier Pérez Gisbert, Ana Gutiérrez Casbas, Edouard Louis, Marco Marino, Gareth Parkes, Fraser Cummings, Bindia Jharap, Jens Kjeldsen, Luís Correia, Paula Ministro, Matthias Ebert, Erik Hertervig, Dirk Staessen, Joris Dutré, Arnaud Colard, Graham Morrison, Henning Glerup, Jens Frederik Dahlerup, Frank Wolfhagen, Marian Batovsky, Martin Molnar, Barbora Kadleckova, Paulo Caldeira, David Laharie, Xavier Hebuterne, Bruno Bonaz, Matthieu Allez, Andreas Fischer, Joaquín Ernesto Hinojosa Del Val, Miriam Mañosa Ciria, Jose Manuel Herrera Justiniano, Charlotte Soderman, Rajiv Chandy, Craig Mowat, Peter Irving, Jan Fallingborg, Jan Matous, Tomas Douda, Romain Altwegg, Jose Manuel Benitez, María Teresa Arroyo Villarino, Jordi Guardiola Capón, Daniel Ginard Vicenc, Pieter Dewint, Sven Almer, Sebastien Kindt

Publikováno v: Danese, S, Vermeire, S, D'Haens, G, Panés, J, Dignass, A, Magro, F, Nazar, M, Le Bars, M, Lahaye, M, Ni, L, Bravata, I, Lavie, F, Daperno, M, Lukáš, M, Armuzzi, A, Löwenberg, M, Gaya, D R, Peyrin-Biroulet, L & STARDUST study group 2022, ' Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST) : an open-label, multicentre, randomised phase 3b trial ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 4, pp. 294-306 . https://doi.org/10.1016/S2468-1253(21)00474-X
lancet. Gastroenterology & hepatology, 7(4), 294-306. Elsevier Limited
The Lancet Gastroenterology and Hepatology, 7(4), 294-306. Elsevier Ltd

Background: A treat-to-target strategy, in which strictly defined treatment targets facilitate decision making in clinical practice, is advocated as an optimised management approach for some chronic disorders. The aim of the STARDUST trial was to ass

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c41ea76bc7f88c535499cddcf9ba8ad
https://pure.au.dk/portal/da/publications/treat-to-target-versus-standard-of-care-for-patients-with-crohns-disease-treated-with-ustekinumab-stardust(6e02a521-a146-4afb-857c-d91bbe745a10).html

An atypical cause of right lower abdominal pain: amoebiasis, a family cluster

Autor: T De Somer, D. Baert, Pieter Dewint, M Deceuninck, D Marichal, C Gabriel, C. Van Steenkiste, E Vanderstraeten

Publikováno v: Acta gastro-enterologica belgica

In this case report we present a Family cluster of amoebiasis in a nonendemic region. A 46-year-old women, diagnosed with Crohn's disease for which she received no maintenance therapy, was evaluated for the suspicion of a flare. At colonuscopy howeve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd502f7987782a3a79fa3c444f131a7
https://pubmed.ncbi.nlm.nih.gov/34217188

A plethora of manifestations following a Mycoplasma pneumoniae infection: a case report

Autor: Delphine Mtf Vervloet, E Vanderstraeten, Pieter Dewint, Sébastien Kindt, Imke Matthys, Christophe Van Steenkiste, Sophia Steyaert, Peter Sinnaeve, Kristoff Cornelis, Daniel Borsboom, Valérie Lambrecht

Publikováno v: Acta Clinica Belgica. 75:229-234

Mycoplasma pneumoniae infection can present with a plethora of symptoms and result in a systemic vasculitis by activating a cascade of autoimmune reactions. In this case report, a young man without relevant past medical history was admitted to the ho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcdb628c780f97706ab34c61bdce0dc8
https://doi.org/10.1080/17843286.2019.1578029

P281 Evaluation of trough level and disease activity after switch from adalimumab originator to biosimilar in patients with Inflammatory Bowel Disease

Autor: D. Baert, N Deprez, V Mattens, M Deceuninck, T De Somer, S Vanden Branden, E Vanderstraeten, I Huys, J Vandervoort, Pieter Dewint, A Sterckx, N Vanheddegem

Publikováno v: Journal of Crohn's and Colitis. 15:S314-S315

Background SB5 is approved as a biosimilar to the adalimumab (ADA) originator. Bio- and efficacy equivalence, as well as comparable safety and immunogenicity have been demonstrated in Phase I and III randomised clinical trials. In this study we want

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9981b26e928f497714b7b39610727626
https://doi.org/10.1093/ecco-jcc/jjab076.406

ID: 3526588 COMPUTER AIDED DETECTION (CADE) IN COLONOSCOPY: AN END-USER EXPERIENCE USING TWO SYSTEMS

Autor: Pieter Dewint, Walgraeve Daan, Stefan Van Langendonck, Pieter Corens, E Vanderstraeten, Souad Bouhadan, Elisabeth Stragier

Publikováno v: Gastrointestinal Endoscopy. 93:AB187

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e105f8f162dc602ec86462a39e80a52b
https://doi.org/10.1016/j.gie.2021.03.425